Benchmark Research, for the fourth time in six years, has been named Best Clinical Trial Site or Network at the 9th annual Vaccine Industry Excellence Awards, presented at the 16th annual World Vaccine Congress in Washington, DC.
April 08, 2016 -- Benchmark Research, based in Austin Texas, has been named Best Clinical Trial Site or Network at the 9th annual Vaccine Industry Excellence (ViE) Awards. PMG Research, a Benchmark Research collaborator in the VaxCorps vaccine consortium, together with Miami Research Associates, was named Highly Commended in the Best Clinical Trial Site or Network category.
Winners were announced at a ceremony held during the 16th annual World Vaccine Congress in Washington, DC. In the six-year history of this award, Benchmark Research has been one of the top finalists all six times; with this year’s win marking their 4th time as the Best Clinical Trial Site or Network.
“While we’re thrilled that our colleagues and clients have presented us with this prestigious award, we’re equally excited about the opening of Benchmark Urgent & Family Care this June. Vaccines have traditionally been the focus of our research, but the opening of our urgent care facilities will allow us to expand our patient database, take on a wider variety of indications, and provide added value to the patients and clients that we serve,” said Mark Lacy, CEO of Benchmark Research.
Benchmark Research is a geographically diverse, fully-integrated network of multi-therapeutic research centers across three states. In the coming months, they will be adding three Urgent & Family Care Centers to their portfolio with several more to follow. Benchmark continues to both expand and innovate in their quest to maintain their standing as the leading site network in the clinical research industry.